• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性胆汁性肝硬化中肝胆转运体表达的适应性变化。

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.

作者信息

Zollner Gernot, Fickert Peter, Silbert Dagmar, Fuchsbichler Andrea, Marschall Hanns Ulrich, Zatloukal Kurt, Denk Helmut, Trauner Michael

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Karl-Franzens University, Auenbruggerplatz 15, A-8036, Graz, Austria.

出版信息

J Hepatol. 2003 Jun;38(6):717-27. doi: 10.1016/s0168-8278(03)00096-5.

DOI:10.1016/s0168-8278(03)00096-5
PMID:12763363
Abstract

BACKGROUND/AIMS: Information about alterations of hepatobiliary transporter expression in primary biliary cirrhosis (PBC) could provide important insights into the pathogenesis of cholestasis. This study aimed to determine the expression of hepatobiliary transport systems for bile salts (Na(+)/taurocholate cotransporter, NTCP; bile salt export pump, BSEP), organic anions (organic anion transporting protein, OATP2; canalicular conjugate export pump, MRP2; basolateral MRP homologue, MRP3), organic cations (canalicular multidrug export pump, MDR1), and phospholipids (canalicular phospholipid flippase MDR3) in livers from patients with advanced stages of PBC.

METHODS

Transporter mRNA and protein levels were assessed by reverse transcription polymerase chain reaction and Western blot analysis. Tissue distribution of transporters was investigated by immunohistochemistry and immunofluorescence microscopy. Hepatic bile acids were measured by gas chromatography-mass spectrometry.

RESULTS

Compared to controls, basolateral uptake systems (NTCP, OATP2) were reduced, canalicular export pumps for bile salts and bilirubin (BSEP, MRP2) were preserved, while canalicular MDR P-glycoproteins (MDR1, MDR3) and the basolateral efflux pump MRP3 were increased in PBC. Double immunofluorescence labeling with a canalicular marker (dipeptidyl peptidase IV) demonstrated proper canalicular localization of BSEP and MRP2 in PBC. OATP2 and MRP2 expression correlated inversely with hepatic levels of hydrophobic bile acids, while positively correlating with hepatic enrichment with ursodeoxycholic acid.

CONCLUSIONS

Down-regulation of basolateral uptake systems and maintenance/up-regulation of canalicular and basolateral efflux pumps may represent adaptive mechanisms limiting the accumulation of toxic biliary constituents.

摘要

背景/目的:原发性胆汁性肝硬化(PBC)中肝胆转运体表达改变的相关信息可为胆汁淤积的发病机制提供重要见解。本研究旨在确定晚期PBC患者肝脏中胆盐(钠离子/牛磺胆酸盐共转运体,NTCP;胆盐输出泵,BSEP)、有机阴离子(有机阴离子转运蛋白,OATP2;胆小管共轭输出泵,MRP2;基底外侧MRP同源物,MRP3)、有机阳离子(胆小管多药输出泵,MDR1)和磷脂(胆小管磷脂翻转酶MDR3)的肝胆转运系统的表达情况。

方法

通过逆转录聚合酶链反应和蛋白质免疫印迹分析评估转运体的mRNA和蛋白水平。通过免疫组织化学和免疫荧光显微镜研究转运体的组织分布。采用气相色谱-质谱法测定肝脏胆汁酸。

结果

与对照组相比,基底外侧摄取系统(NTCP、OATP2)减少,胆盐和胆红素的胆小管输出泵(BSEP、MRP2)保持不变,而PBC中胆小管MDR P-糖蛋白(MDR1、MDR3)和基底外侧外排泵MRP3增加。用胆小管标记物(二肽基肽酶IV)进行双重免疫荧光标记显示PBC中BSEP和MRP2在胆小管定位正常。OATP2和MRP2的表达与肝脏中疏水胆汁酸水平呈负相关,而与肝脏中熊去氧胆酸的富集呈正相关。

结论

基底外侧摄取系统的下调以及胆小管和基底外侧外排泵的维持/上调可能代表了限制有毒胆汁成分蓄积的适应性机制。

相似文献

1
Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.原发性胆汁性肝硬化中肝胆转运体表达的适应性变化。
J Hepatol. 2003 Jun;38(6):717-27. doi: 10.1016/s0168-8278(03)00096-5.
2
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.胆汁淤积性肝病患者经皮肝穿刺活检中肝胆转运体的表达
Hepatology. 2001 Mar;33(3):633-46. doi: 10.1053/jhep.2001.22646.
3
Hepatobiliary transport.肝胆转运
J Hepatol. 2000;32(1 Suppl):3-18. doi: 10.1016/s0168-8278(00)80411-0.
4
Hepatobiliary transporter expression in human hepatocellular carcinoma.人类肝细胞癌中肝胆转运蛋白的表达
Liver Int. 2005 Apr;25(2):367-79. doi: 10.1111/j.1478-3231.2005.01033.x.
5
Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症中肝胆转运蛋白的表达与定位
Hepatology. 2005 May;41(5):1160-72. doi: 10.1002/hep.20682.
6
Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis.原发性胆汁性肝硬化中肝细胞转运体和根蛋白的表达及定位变化
J Hepatol. 2003 Nov;39(5):693-702. doi: 10.1016/s0168-8278(03)00410-0.
7
Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes.原代培养大鼠肝细胞中窦状隙和胆小管有机阴离子转运系统的胆汁淤积表达模式
Hepatology. 2001 Apr;33(4):776-82. doi: 10.1053/jhep.2001.23433.
8
The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.接受胆汁引流患者胆汁淤积性肝脏中质膜转运蛋白的表达水平及其与胆汁分泌功能损害的关联。
Am J Gastroenterol. 2001 Dec;96(12):3368-78. doi: 10.1111/j.1572-0241.2001.05339.x.
9
Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.熊去氧胆酸和胆酸喂养对小鼠肝脏肝细胞转运体表达的影响。
Gastroenterology. 2001 Jul;121(1):170-83. doi: 10.1053/gast.2001.25542.
10
Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver.大鼠肝脏再生过程中基底外侧和胆小管有机阴离子转运体的差异表达
Gastroenterology. 1999 Dec;117(6):1408-15. doi: 10.1016/s0016-5085(99)70291-x.

引用本文的文献

1
Differential Protective Roles of c-Jun N-terminal Kinase-2 in Nonparenchymal Liver Cells and Hepatocytes During Cholestasis.c-Jun氨基末端激酶2在胆汁淤积期间非实质肝细胞和肝细胞中的不同保护作用
Cell Mol Gastroenterol Hepatol. 2025 Jul 16;19(11):101588. doi: 10.1016/j.jcmgh.2025.101588.
2
Beyond ADME: The Endogenous Functions of Drug Transporters and Its Impact on Human Disease.超越药物代谢动力学:药物转运体的内源性功能及其对人类疾病的影响。
Pharmaceutics. 2025 May 23;17(6):685. doi: 10.3390/pharmaceutics17060685.
3
Chishao () alleviates intra-hepatic cholestasis by modulating NTCP in rats.
赤芍通过调节大鼠的钠-牛磺胆酸共转运蛋白(NTCP)减轻肝内胆汁淤积。
Front Pharmacol. 2024 Feb 1;15:1341651. doi: 10.3389/fphar.2024.1341651. eCollection 2024.
4
Regulation of ABC transporters by sex steroids may explain differences in drug resistance between sexes.性激素对 ABC 转运蛋白的调节可能解释了性别间药物耐药性的差异。
J Physiol Biochem. 2023 Aug;79(3):467-487. doi: 10.1007/s13105-023-00957-1. Epub 2023 Mar 30.
5
Bile Acids and Biliary Fibrosis.胆汁酸与胆汁性纤维化。
Cells. 2023 Mar 2;12(5):792. doi: 10.3390/cells12050792.
6
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.胆汁酸及其受体在胃肠道和肝脏病理生理学中的作用。
Nat Rev Gastroenterol Hepatol. 2022 Jul;19(7):432-450. doi: 10.1038/s41575-021-00566-7. Epub 2022 Feb 14.
7
The Effect of Exogenous Bile Acids on Antioxidant Status and Gut Microbiota in Heat-Stressed Broiler Chickens.外源性胆汁酸对热应激肉鸡抗氧化状态和肠道微生物群的影响
Front Nutr. 2021 Nov 24;8:747136. doi: 10.3389/fnut.2021.747136. eCollection 2021.
8
Novel therapeutic targets for cholestatic and fatty liver disease.胆汁淤积性和脂肪性肝病的新型治疗靶点。
Gut. 2022 Jan;71(1):194-209. doi: 10.1136/gutjnl-2021-324305. Epub 2021 Oct 6.
9
Review article: therapeutic aspects of bile acid signalling in the gut-liver axis.综述文章:肠道-肝脏轴中胆汁酸信号转导的治疗作用。
Aliment Pharmacol Ther. 2021 Nov;54(10):1243-1262. doi: 10.1111/apt.16602. Epub 2021 Sep 23.
10
Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.ω-3 多不饱和脂肪酸:改善熊去氧胆酸反应性的药物-营养治疗方法。
Nutrients. 2021 Jul 29;13(8):2617. doi: 10.3390/nu13082617.